Controlled release kinetics of p-aminosalicylic acid from biodegradable crosslinked polyesters for enhanced anti-mycobacterial activity

Acta Biomater. 2016 Jan:30:168-176. doi: 10.1016/j.actbio.2015.11.032. Epub 2015 Nov 17.

Abstract

Unlike conventional polymeric drug delivery systems, where drugs are entrapped in polymers, this study focuses on the incorporation of the drug into the polymer backbone to achieve higher loading and sustained release. Crosslinked, biodegradable, xylitol based polyesters have been synthesized in this study. The bioactive drug moiety, p-aminosalicylic acid (PAS), was incorporated in xylitol based polyesters to impart its anti-mycobacterial activity. To understand the influence of the monomer chemistry on the incorporation of PAS and its subsequent release from the polymer, different diacids have been used. Controlled release profiles of the drug from these polyesters were studied under normal physiological conditions. The degradation of the polyesters varied from 48% to 76% and the release of PAS ranged from 54% to 65% of its initial loading in 7days. A new model was developed to explain the release kinetics of PAS from the polymer that accounted for the polymer degradation and drug concentration. The thermal, mechanical, drug release and cytocompatibility properties of the polymers indicate their suitability in biomedical applications. The released products from these polymers were observed to be pharmacologically active against Mycobacteria. The high drug loading and sustained release also ensured enhanced efficacy. These polymers form biocompatible, biodegradable polyesters where the sustained release of PAS may be tailored for potential treatment of mycobacterial infections.

Statement of significance: In the present work, we report on novel polyesters with p-aminosalicylic acid (PAS) incorporated in the polymer backbone. The current work aims to achieve controlled release of PAS and ensures the delivered PAS is stable and pharmacologically active. The novelty of this work primarily involves the synthetic chemistry of polymerization and detailed analysis and efficacy of active PAS delivery. A new kinetic model has been developed to explain the PAS release profiles. These polymers are biodegradable, cytocompatible and anti-mycobacterial in nature.

Keywords: Biodegradable polymers; Controlled release; Mycobacteria; Polyesters; p-aminosalicylic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminosalicylic Acid* / chemistry
  • Aminosalicylic Acid* / pharmacokinetics
  • Aminosalicylic Acid* / pharmacology
  • Animals
  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacokinetics
  • Anti-Bacterial Agents* / pharmacology
  • Biodegradable Plastics* / chemistry
  • Biodegradable Plastics* / pharmacokinetics
  • Biodegradable Plastics* / pharmacology
  • Delayed-Action Preparations / chemistry
  • Delayed-Action Preparations / pharmacokinetics
  • Delayed-Action Preparations / pharmacology
  • Mice
  • Mycobacterium / growth & development*
  • Mycobacterium Infections / drug therapy*
  • Mycobacterium Infections / metabolism
  • Mycobacterium Infections / pathology
  • NIH 3T3 Cells
  • Polyesters* / chemistry
  • Polyesters* / pharmacokinetics
  • Polyesters* / pharmacology

Substances

  • Anti-Bacterial Agents
  • Biodegradable Plastics
  • Delayed-Action Preparations
  • Polyesters
  • Aminosalicylic Acid